WFOF in Dentistry: Wide Field Optical Fluorescence Explained

Modern dentistry is rapidly evolving beyond traditional visual examination and radiographic imaging. As clinicians strive to detect disease earlier, improve diagnostic accuracy, and deliver minimally invasive care, Wide Field Optical Fluorescence (WFOF) has emerged as one of the most promising adjunctive diagnostic technologies in contemporary dental practice.

Originally introduced for the early detection of oral potentially malignant disorders (OPMDs) and oral squamous cell carcinoma (OSCC), WFOF has gradually demonstrated applications far beyond oral cancer screening. Recent clinical research has shown that fluorescence imaging can assist clinicians in identifying mature oral biofilm, monitoring peri-implant diseases, differentiating benign oral lesions, evaluating restoration integrity, and guiding preventive treatment—all in real time without ionizing radiation, dyes, or invasive procedures.

Unlike conventional oral examinations that rely solely on visible changes in tissue colour and morphology, WFOF reveals biochemical and structural alterations occurring beneath the tissue surface. These changes often develop long before they become clinically apparent, making fluorescence imaging a valuable adjunct for early diagnosis and patient monitoring.

The technology is particularly attractive because examinations take less than two minutes, require no patient preparation, produce immediate results, and can easily be incorporated into routine dental check-ups. As awareness of preventive dentistry continues to grow, fluorescence-guided diagnostics are expected to become increasingly common in general practice, implantology, oral medicine, and oral surgery.

This article explores the science behind Wide Field Optical Fluorescence, its clinical applications, the latest research evidence, and the best WFOF devices currently available for dental professionals in the UK.

What is WFOF (Wide Field Optical Fluorescence)?

Wide Field Optical Fluorescence (WFOF), also known as oral autofluorescence imaging, is a non-invasive optical diagnostic technique that enables clinicians to visualize biological changes within oral tissues using specific wavelengths of blue or violet light, typically between 400 and 460 nm.

The principle behind WFOF is based on autofluorescence, a natural phenomenon in which endogenous fluorophores within oral tissues absorb excitation light and emit light of a different wavelength. Healthy oral tissues contain naturally fluorescent molecules such as:

• Collagen
• Elastin
• Flavin adenine dinucleotide (FAD)
• Nicotinamide adenine dinucleotide (NADH)
• Keratin

When illuminated with blue light, these fluorophores emit a characteristic pale green fluorescence. Healthy mucosa therefore appears bright green through the fluorescence filter.

However, pathological changes alter this optical behaviour.

Inflammation, epithelial dysplasia, neoplastic transformation, bacterial colonization, increased vascularity, and collagen degradation all reduce normal fluorescence, creating dark or reddish areas that may indicate underlying pathology.

Unlike radiographs, which demonstrate mineralized structures, fluorescence imaging provides functional information regarding tissue metabolism and architecture. This enables clinicians to detect subtle abnormalities that may not yet be visible during conventional clinical examination.

How Does WFOF Work?

The examination follows a relatively simple optical process:

1. The operatory lights are dimmed.
2. The oral cavity is illuminated using a dedicated blue LED light source (approximately 400–460 nm).
3. An optical filter blocks reflected excitation light while allowing emitted fluorescence to reach the observer.
4. The clinician evaluates fluorescence patterns throughout the oral cavity.

Healthy tissues generally fluoresce bright green due to intact collagen architecture.

Conversely:

• Dysplastic or malignant lesions often appear as dark fluorescence loss.
• Mature bacterial biofilm emits orange or red fluorescence because of bacterial porphyrins.
• Hyperkeratinized lesions may demonstrate increased green fluorescence.
• Certain restorative materials exhibit characteristic fluorescence, helping clinicians evaluate restoration integrity.

Unlike staining agents used for plaque disclosure, fluorescence imaging does not require dyes or chemicals and therefore avoids allergic reactions and unwanted staining of restorations or prostheses.

Biological Basis of Fluorescence

The diagnostic capability of WFOF arises from changes occurring at both cellular and extracellular levels.

Healthy connective tissue contains dense collagen fibres that produce strong green fluorescence. During inflammation or malignant transformation, collagen degradation and increased blood vessel formation reduce fluorescence intensity because haemoglobin absorbs excitation light.

Meanwhile, mature anaerobic bacteria—including Porphyromonas gingivalis, Prevotella intermedia, Treponema denticola, Fusobacterium nucleatum, and Aggregatibacter actinomycetemcomitans—produce porphyrins that fluoresce orange-red under blue light.

This explains why mature pathogenic plaque can be visualized without disclosing agents.

The ability to simultaneously evaluate tissue health and bacterial activity makes WFOF unique among chairside diagnostic technologies.

Importance of WFOF in Dental Diagnosis

The philosophy of modern dentistry has shifted from treating advanced disease toward identifying pathology at its earliest possible stage. Wide Field Optical Fluorescence aligns perfectly with this preventive approach by enabling clinicians to recognize tissue alterations before they become clinically obvious.

Although WFOF should never replace conventional examination or histopathological confirmation, numerous studies have demonstrated its value as an adjunctive diagnostic tool that enhances clinical confidence and improves patient management.

One of its greatest strengths is the ability to identify lesions requiring further investigation. During routine examinations, clinicians may encounter subtle mucosal changes that are difficult to differentiate visually. Fluorescence imaging highlights areas demonstrating altered metabolic activity, allowing practitioners to determine whether biopsy, referral, or close monitoring is appropriate.

Beyond oral pathology, fluorescence technology has become increasingly valuable in preventive dentistry. Mature biofilm is usually transparent and difficult to visualize, particularly around implants and prosthetic restorations. Traditional plaque disclosing agents effectively stain biofilm but can discolor composite restorations, acrylic prostheses, and implant restorations while also carrying a small risk of allergic reactions.

Wide Field Optical Fluorescence eliminates these disadvantages.

The study by Andrade et al. demonstrated that mature oral biofilm exhibits intense reddish fluorescence due to bacterial porphyrins. Using WFOF, clinicians could rapidly identify plaque accumulation around implants, verify complete biofilm removal after professional cleaning, evaluate restoration margins, and monitor healing during peri-implant mucositis treatment.

An additional advantage is improved patient education. Patients frequently underestimate the amount of plaque remaining after brushing because mature biofilm is colourless. When shown vivid red fluorescence images of bacterial accumulation, patient understanding and motivation for oral hygiene often improve significantly.

WFOF also enhances documentation and longitudinal monitoring. Digital fluorescence images can be stored in patient records, allowing clinicians to compare lesions over time and evaluate treatment outcomes objectively.

Importantly, the examination is:

• Non-invasive
• Radiation-free
• Painless
• Dye-free
• Immediate
• Repeatable
• Suitable for routine recall appointments

As artificial intelligence becomes increasingly integrated into dentistry, fluorescence imaging is also expected to play a growing role in automated lesion detection and risk assessment. AI-assisted interpretation of fluorescence images may further improve diagnostic consistency and reduce operator variability.

Applications of WFOF in Dental Practice

While WFOF was initially developed to assist in the early detection of oral cancer, advances in optical imaging and a growing body of clinical research have significantly expanded its applications. Today, fluorescence imaging is increasingly used across multiple dental disciplines, including oral medicine, implantology, periodontology, restorative dentistry, and preventive care.

The technology provides clinicians with immediate visual information regarding tissue health, bacterial activity, restoration quality, and lesion characteristics without exposing patients to ionizing radiation or invasive procedures.

Importantly, WFOF should be regarded as a clinical adjunct rather than a standalone diagnostic tool. Clinical examination, radiographic assessment, histopathological analysis, and patient history remain essential components of comprehensive diagnosis. Nevertheless, fluorescence imaging provides additional information that may otherwise remain undetected during routine examination.

Recent studies suggest that WFOF is particularly valuable in detecting mature oral biofilm, monitoring peri-implant health, screening for oral potentially malignant disorders, and differentiating certain benign oral lesions.

The following sections explore its principal clinical applications.

Visualization of Oral Biofilm

One of the most exciting recent developments in fluorescence dentistry is the use of WFOF for the visualization of mature oral biofilm.

Dental plaque is generally transparent and therefore difficult to identify clinically without plaque disclosing solutions. Although disclosing agents remain effective, they present several disadvantages, including temporary staining of teeth, restorations, prosthetic materials, and soft tissues. Some formulations may also trigger allergic reactions in susceptible individuals.

Wide Field Optical Fluorescence offers a completely dye-free alternative.

Under blue-violet excitation light (approximately 400–405 nm), mature biofilm containing Gram-negative anaerobic bacteria emits a characteristic orange-red fluorescence due to naturally occurring bacterial porphyrins. These fluorescence patterns enable clinicians to rapidly identify areas of plaque accumulation, particularly around implant restorations, crown margins, orthodontic appliances, and interproximal surfaces.

In their landmark clinical report, Andrade et al. (2021) demonstrated that WFOF successfully identified mature oral biofilm around dental implants and natural teeth in a patient presenting with peri-implant mucositis. Following professional debridement and oral hygiene reinforcement, the previously observed red fluorescence disappeared during follow-up examinations, correlating with clinical resolution of inflammation.

The authors also demonstrated several additional clinical benefits:

• Evaluation of implant screw access restoration integrity.
• Detection of secondary caries.
• Confirmation of complete plaque removal after professional cleaning.
• Improved patient motivation through visual education.
• Elimination of plaque-disclosing dyes and their associated disadvantages.

These findings suggest that WFOF may become an invaluable tool for preventive dentistry and implant maintenance protocols, particularly in practices focused on periodontal and peri-implant disease prevention.

Diagnosis of Peri-implant Mucositis Using WFOF

Peri-implant diseases have become one of the most significant biological complications associated with implant therapy. As the number of dental implants placed worldwide continues to rise, clinicians are increasingly challenged by peri-implant mucositis and peri-implantitis, both of which are strongly associated with bacterial biofilm accumulation. Early detection and effective plaque control remain the cornerstones of successful long-term implant maintenance.

Wide Field Optical Fluorescence (WFOF) has recently emerged as a valuable adjunctive technology for the visualization of mature peri-implant biofilm and the monitoring of peri-implant tissue health.

Unlike conventional plaque disclosure agents, WFOF enables clinicians to identify pathogenic biofilm instantly without the use of dyes. Mature Gram-negative anaerobic bacteria produce endogenous porphyrins that fluoresce orange-red when illuminated with blue-violet light (approximately 400–405 nm). This characteristic fluorescence allows clinicians to distinguish mature pathogenic plaque from healthy implant surfaces in real time.

The landmark case report by Andrade et al. demonstrated the practical clinical value of WFOF during routine implant maintenance. A 55-year-old patient presented with peri-implant mucositis characterized by erythema, oedema and bleeding around implant-supported prostheses. Under fluorescence imaging, the affected implant regions exhibited intense reddish fluorescence corresponding to mature bacterial biofilm.

Following professional mechanical debridement, polishing and individualized oral hygiene instruction, repeat WFOF examinations performed after 15 and 30 days showed progressive disappearance of the red fluorescence. Clinical resolution of inflammation occurred simultaneously with the disappearance of fluorescence, illustrating a direct relationship between bacterial biofilm removal and peri-implant tissue healing.

An additional benefit observed in the study was the ability of WFOF to evaluate the integrity of implant screw access restorations. Properly sealed composite restorations demonstrated bright green fluorescence, whereas defective restorations or marginal leakage may allow bacterial penetration, potentially producing red fluorescence associated with biofilm accumulation. This provides clinicians with a rapid method of assessing restoration quality during routine maintenance appointments.

Another important advantage is patient education. Because mature plaque is often invisible to patients, demonstrating vivid fluorescence images significantly improves understanding of oral hygiene deficiencies and motivates behavioural change. Rather than relying solely on verbal explanations, clinicians can visually demonstrate exactly where plaque persists around implants.

Clinical Benefits of WFOF in Implant Dentistry

• Immediate visualization of mature peri-implant biofilm.
• Early identification of peri-implant mucositis.
• Guidance during professional implant debridement.
• Verification of complete biofilm removal.
• Assessment of implant restoration integrity.
• Improved patient motivation and compliance.
• No staining of implant prostheses or restorative materials.
• No consumable dyes or plaque disclosing solutions required.

Although WFOF cannot diagnose peri-implantitis independently, it provides valuable biological information that complements conventional periodontal probing, bleeding on probing, radiographic examination and clinical assessment.

Diagnosis of Oral Cancer Using WFOF

Early diagnosis remains the single most important factor influencing survival rates for oral squamous cell carcinoma (OSCC). Unfortunately, many malignant and potentially malignant oral lesions remain asymptomatic during their early stages and may closely resemble benign inflammatory lesions, making clinical diagnosis challenging.

Wide Field Optical Fluorescence has become one of the most widely investigated adjunctive technologies for oral cancer screening.

The biological basis of fluorescence diagnosis is well understood. Healthy oral mucosa contains abundant collagen cross-links and naturally fluorescent metabolic cofactors such as flavins and NADH. These fluorophores produce a characteristic pale green fluorescence when stimulated by blue-violet light.

During dysplasia or malignant transformation, several biological alterations occur simultaneously:

• Breakdown of stromal collagen.
• Increased epithelial thickness.
• Neovascularization.
• Increased haemoglobin concentration.
• Altered cellular metabolism.
• Increased nuclear-to-cytoplasmic ratio.

Collectively, these changes reduce tissue autofluorescence, resulting in localized fluorescence loss that appears as dark or black areas during WFOF examination.

Numerous studies have demonstrated that WFOF can improve visualization of suspicious oral lesions that may otherwise be overlooked during routine examination. It is particularly useful for identifying lesion margins before biopsy and monitoring patients with known oral potentially malignant disorders such as:

• Leukoplakia
• Erythroplakia
• Oral lichen planus with dysplastic changes
• Actinic cheilitis
• Chronic traumatic lesions requiring review

However, clinicians must understand an important limitation of fluorescence imaging.

Loss of fluorescence is not specific for cancer.

Inflammation, trauma, vascular lesions, ulceration and certain infections may also produce fluorescence loss. Therefore, WFOF should always be considered an adjunctive examination rather than a replacement for conventional clinical examination or biopsy.

Current international recommendations continue to regard histopathological examination as the diagnostic gold standard.

Nevertheless, WFOF offers several practical advantages:

• Enhanced visualization of lesion boundaries.
• Screening of high-risk patients.
• Documentation of lesion progression.
• Guidance for biopsy site selection.
• Longitudinal monitoring following treatment.

As awareness of oral cancer continues to increase, fluorescence-guided screening is becoming an increasingly valuable component of comprehensive oral medicine practice.

Clinical Differentiation of Squamous Cell Papilloma Using WFOF

Although oral squamous papilloma is a benign epithelial lesion, its clinical appearance may resemble other exophytic lesions, making differential diagnosis difficult during routine examination.

Most oral squamous papillomas are associated with Human Papillomavirus (HPV), particularly low-risk subtypes HPV-6 and HPV-11. While these lesions rarely undergo malignant transformation, distinguishing them from potentially malignant lesions remains essential.

Recent clinical evidence suggests that WFOF may provide additional diagnostic information during clinical assessment.

In the published case report “Oral Squamous Papilloma: A View under Clinical, Fluorescence and Histopathological Aspects,” clinicians examined an oral squamous papilloma using wide-field optical fluorescence before surgical excision.

Unlike malignant lesions that typically demonstrate pronounced fluorescence loss, the papilloma exhibited a predominantly green fluorescence pattern with localized areas of red fluorescence. Histopathological examination subsequently confirmed benign squamous papilloma characterized by:

• Hyperkeratosis.
• Papillomatosis.
• Hypergranulosis.
• Acanthosis.
• Mild inflammatory infiltrate.

The observed fluorescence pattern reflected these histological features.

The preserved green fluorescence corresponded to hyperkeratinized tissue, while the small areas of reddish fluorescence were believed to originate from bacterial porphyrins colonizing the rough papillary surface rather than malignant transformation.

An additional advantage of WFOF was its ability to confirm that no additional occult lesions were present elsewhere within the oral cavity during the same appointment.

The authors concluded that fluorescence imaging provides valuable supplementary information during the clinical assessment of papillomatous lesions by:

• Improving lesion visualization.
• Defining lesion margins.
• Screening the remainder of the oral cavity.
• Supporting differential diagnosis.
• Assisting surgical planning.

Importantly, the study emphasizes that fluorescence findings must always be interpreted alongside clinical examination and confirmed by histopathological analysis.

Best Available WFOF Devices in the UK Market

As fluorescence-guided diagnosis gains popularity, several manufacturers now offer dedicated oral fluorescence devices. These systems differ in optical technology, image quality, regulatory approvals and price, making device selection dependent on clinical needs and budget.

For UK dental practices, the following systems currently represent the most relevant options.

Which Device Should You Choose?

The ideal WFOF device depends on your practice profile and diagnostic objectives.

• VELscope Vx remains the benchmark for clinicians focused on oral medicine, oral surgery and oral cancer screening due to its extensive clinical validation.
• GOCCLES offers an exceptionally cost-effective solution for general dental practices, integrating seamlessly with existing curing lights.
• OralID uses tissue autofluorescence visualization (AFV), one of the most established adjunctive optical techniques for oral cancer screening.
• Identafi 3000 may appeal to specialists interested in multispectral imaging, although its availability in the UK is currently limited.
• Oralitest uses tissue autofluorescence visualization (AFV), the same fundamental optical principle as VELscope and OralID, but in a head-mounted design.

The Future of WFOF in Digital Dentistry

The integration of Wide Field Optical Fluorescence (WFOF) into everyday dental practice represents more than the adoption of another diagnostic device—it marks a shift toward preventive, minimally invasive, and data-driven dentistry. As digital workflows continue to transform clinical practice, fluorescence imaging is expected to become an increasingly important component of comprehensive oral examinations.

Traditionally, WFOF has been regarded primarily as an adjunctive tool for oral cancer screening. However, recent research demonstrates that its applications extend well beyond this original purpose. Today, clinicians are using fluorescence imaging to visualize mature oral biofilm, monitor peri-implant health, evaluate restoration integrity, assist in lesion differentiation, and improve patient education.

One of the most exciting developments is the integration of artificial intelligence (AI) with fluorescence imaging. AI algorithms are being developed to analyze fluorescence patterns, identify suspicious lesions, quantify fluorescence intensity, and assist clinicians in detecting subtle abnormalities that might otherwise be overlooked. Such systems could improve diagnostic consistency, reduce operator variability, and facilitate longitudinal monitoring of disease progression.

Cloud-based digital dentistry platforms may also allow fluorescence images to become part of a patient’s permanent electronic record. By comparing images captured during routine recall appointments, clinicians can objectively monitor tissue changes over time and evaluate treatment outcomes with greater precision.

In implant dentistry, fluorescence imaging could become an essential component of preventive maintenance protocols. Early visualization of mature biofilm before clinical inflammation develops may enable intervention before peri-implant mucositis progresses to peri-implantitis, reducing biological complications and improving long-term implant survival.

Similarly, the combination of WFOF with intraoral scanners may create entirely new diagnostic workflows. Future intraoral scanners may incorporate fluorescence imaging directly into the scanning process, allowing clinicians to simultaneously obtain digital impressions, detect carious lesions, visualize biofilm, and screen oral soft tissues during a single appointment.

From a public health perspective, WFOF also has considerable potential. Compared with many advanced imaging modalities, fluorescence devices are relatively affordable, require minimal maintenance, produce immediate results, and do not expose patients to ionizing radiation. These characteristics make them attractive not only for specialist clinics but also for general dental practices, community oral health programs, dental schools, and outreach screening initiatives.

While additional high-quality clinical studies are still needed to further define the diagnostic accuracy of WFOF across different oral diseases, the existing evidence strongly supports its role as an adjunctive diagnostic technology. As digital dentistry continues to evolve, fluorescence-guided diagnosis is likely to become an increasingly valuable tool in the clinician’s armamentarium.

Conclusion

Wide Field Optical Fluorescence represents one of the most significant advances in chairside diagnostic imaging in recent years. By visualizing biological and metabolic changes that are invisible under conventional white light, WFOF provides clinicians with valuable additional information that enhances clinical examination without replacing established diagnostic methods.

Current evidence supports its use as an adjunctive tool for:

• Early detection of suspicious oral lesions.
• Oral cancer screening.
• Visualization of mature oral biofilm.
• Diagnosis and monitoring of peri-implant mucositis.
• Evaluation of implant restoration integrity.
• Clinical assessment of benign oral lesions such as squamous papilloma.
• Patient education and preventive care.

The technology offers several practical advantages, including rapid examination, non-invasive imaging, absence of ionizing radiation, elimination of plaque-disclosing dyes, and immediate chairside results. As demonstrated in recent clinical studies, WFOF can improve visualization of mature pathogenic biofilm, facilitate monitoring of peri-implant treatment outcomes, and provide additional information during the assessment of oral mucosal lesions.

Among currently available systems, VELscope Vx remains the most extensively validated device for oral fluorescence examination, while GOCCLES provides an affordable option for routine clinical practice.

As artificial intelligence, digital imaging, and fluorescence technology continue to converge, WFOF is poised to become an integral component of the modern digital dental workflow. For clinicians committed to early diagnosis, minimally invasive dentistry, and evidence-based patient care, adopting fluorescence-guided diagnostics represents an investment in the future of oral healthcare.

Frequently Asked Questions (FAQs)

1. What is Wide Field Optical Fluorescence (WFOF)?

Wide Field Optical Fluorescence (WFOF) is a non-invasive imaging technique that uses blue-violet light (typically 400–460 nm) to stimulate natural tissue fluorescence. It helps dentists identify changes in oral tissues, detect mature biofilm, and screen for suspicious oral lesions.

2. Is WFOF a replacement for biopsy?

No. WFOF is an adjunctive diagnostic tool. While it helps identify suspicious areas that require further investigation, histopathological examination of a biopsy specimen remains the gold standard for definitive diagnosis.

3. Can WFOF detect oral cancer?

WFOF can assist in identifying abnormal tissue that may be associated with oral potentially malignant disorders or oral cancer by revealing areas of fluorescence loss. However, it cannot independently diagnose cancer.

4. How does WFOF visualize dental plaque?

Mature oral biofilm contains anaerobic bacteria that produce porphyrins. Under blue-violet excitation light, these porphyrins emit orange-red fluorescence, making mature plaque visible without plaque-disclosing dyes.

5. Is WFOF useful around dental implants?

Yes. Recent studies have shown that WFOF can effectively visualize mature peri-implant biofilm, assist in diagnosing peri-implant mucositis, monitor treatment progress, and evaluate implant restoration integrity.

6. Does WFOF expose patients to radiation?

No. WFOF uses visible blue light and does not involve ionizing radiation, making it safe for repeated clinical use.

7. Is fluorescence imaging painful?

No. The examination is completely non-contact, painless, and typically takes only one to two minutes.

8. Which WFOF device is considered the industry standard?

VELscope Vx is currently the most widely studied and clinically validated oral fluorescence device. GOCCLES offers a lower-cost alternative, while several emerging Chinese manufacturers provide CE-certified systems for international markets.

9. Can WFOF improve patient education?

Yes. Fluorescence images provide patients with a visual representation of mature plaque accumulation and tissue abnormalities, often improving motivation and compliance with oral hygiene recommendations.

10. Is WFOF suitable for every dental practice?

WFOF can benefit general dentists, periodontists, implantologists, oral surgeons, oral medicine specialists, and dental hygienists. It is particularly valuable for practices focused on preventive dentistry, implant maintenance, and oral cancer screening.

Reference:

1- Use of wide-field optical fluorescence for visualization of oral biofilm in a patient with peri-implant mucositis: a new approach

Sérgio Araújo Andrade ¹, Sebastião Pratavieira ², Vanderlei Salvador Bagnato ², Fernando de Pilla Varotti ¹

2- Oral squamous papilloma: a view under clinical, fluorescence and histopathological aspects

Sérgio Araújo Andrade ¹, Sebastião Pratavieira ², Juliana Fracalossi Paes ³, Marisa Maria Ribeiro ⁴, Vanderlei Salvador Bagnato ², Fernando de Pilla Varotti ¹

3- Lane PM, Gilhuly T, Whitehead P, et al. Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt. 2006;11(2):024006.

4- Poh CF, Zhang L, Anderson DW, et al. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res. 2006;12(22):6716–6722.

5- Farah CS, McCullough MJ. Oral cancer awareness for the general practitioner. Aust Dent J. 2008;53(1):2–10.

6- Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for oral cancer detection. Oral Oncol. 2008;44(1):10–22.

7- Awan KH, Morgan PR, Warnakulasuriya S. Utility of autofluorescence imaging in the diagnosis of oral potentially malignant disorders and oral cancer. J Oral Pathol Med. 2011;40(9):653–660.

8- Pretty IA, Edgar WM, Higham SM. The validation of quantitative light-induced fluorescence to quantify acid erosion of human enamel. Arch Oral Biol. 2004;49(4):285–294.

9- Han SY, Kim BR, Ko HY, et al. Red fluorescence of dental biofilm as an indicator of pathogenic bacterial activity. Photodiagnosis Photodyn Ther. 2016;13:1–7.

10- König K, Hibst R, Meyer H, et al. Laser-induced autofluorescence of carious regions of human teeth. J Dent Res. 1993;72(3):663–671.